Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database.
Nina L WittwerChristoph R MeierCarola A HuberHenriette E Meyer Zu SchwabedissenAllemann SamuelCornelia SchneiderPublished in: Pharmacogenomics and personalized medicine (2022)
The prevalence of PGx drug prescriptions is high in the Swiss population. Therefore, intensified preemptive testing may be a useful option as a substantial amount of the Swiss population might benefit.